top of page
検索

ACCJ The Journal - Advance Medicine - AstraZeneca Japan President Stefan Woxström shares his healthc

2018年4月1日
読了時間: 1分

APRIL 2018 HEALTH

Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision

By C Bryan Jones

Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year.

The ACCJ - 在日米国商工会議所

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

 
 
 

コメント

最新記事
特集記事
多言語・国際イベントの映像配信とテクニカルオペレーション｜LIFE.14 inc. ｜♯ 国際 フォーラム イベント
TOP
SERVICE
CONTACT
PHOTO PORTFOLIO
CORPORATE PORTFOLIO
VIDEO PORTFOLIO
COMPANY
BLOG
SHOP

AVS（Audio Visual Solution）は、株式会社LIFE.14（https://www.life14.com/ ）が提供する、
国際機関・大使館・グローバル企業向けの映像・音響・同時通訳・ライブ配信ワンストップテクニカルサポートです。
英語・フランス語・日本語対応の現場技術チームが国際イベントを成功に導きます。                                                                                                                                                      2026 LIFE.14 Inc. All Rights Reserved.

bottom of page